イタリアのオーソバイオロジクス市場動向(~2021)

GlobalDataが発行した調査報告書(GDMECC1073DB)
◆英語タイトル:Italy Orthobiologics Market Outlook to 2021
◆商品コード:GDMECC1073DB
◆発行会社(リサーチ会社):GlobalData
◆発行日:2015年9月11日
◆ページ数:62
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:イタリア
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥270,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥540,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥810,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Italy Orthobiologics Market Outlook to 2021

Summary

GlobalData’s new report, “Italy Orthobiologics Market Outlook to 2021″, provides key market data on the Italy Orthobiologics market. The report provides value, in millions of US dollars, and volume (in units) and average price data (in US dollars), within market segments – Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

The data in the report is derived from dynamic market forecast models. GlobalData uses epidemiology and capital equipment-based models to estimate and forecast the market size. The objective is to provide information that represents the most up-to-date data of the industry possible.

The epidemiology-based forecasting model makes use of epidemiology data gathered from research publications and primary interviews with physicians to establish the target patient population and treatment flow patterns for individual diseases and therapies. Using prevalence and incidence data and diagnosed and treated population, the epidemiology-based forecasting model arrives at the final numbers.

Capital equipment-based forecasting models are done based on the installed base, replacements and new sales of a specific device/equipment in healthcare facilities such as hospitals, clinics and diagnostic centers. Data for average number of units per facility is used to arrive at the installed base of the capital equipment. Sales for a particular year are arrived at by calculating the replacement units and new units (additional and first-time purchases).

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size for Orthobiologics market categories – Bone Graft and Substitutes, Viscosupplementation and Bone Growth Stimulators.
- Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
- 2014 company shares and distribution shares data for Orthobiologics market.
- Global corporate-level profiles of key companies operating within the Italy Orthobiologics market.
- Key players covered include DePuy Companies, Sanofi, Medtronic, Inc., NuVasive, Inc., Biomet, Inc., Smith & Nephew Plc, Baxter International Inc., Wright Medical Group, Inc. and Stryker Corporation.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.

【レポートの目次】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 What Is This Report About? 6
2.2 Orthobiologics Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 7
3 Orthobiologics Market, Italy 9
3.1 Orthobiologics Market, Italy, Revenue ($m), 2007-2014 9
3.2 Orthobiologics Market, Italy, Revenue ($m), 2014-2021 11
3.2.1 Bone Grafts and Substitutes Market, Italy, Revenue ($m), by Segment, 2007-2014 13
3.2.2 Bone Growth Stimulators Market, Italy, Revenue ($m), by Segment, 2007-2014 15
3.2.3 Viscosupplementation Market, Italy, Revenue ($m), by Segment, 2007-2014 17
3.2.4 Bone Grafts and Substitutes Market, Italy, Revenue ($m), by Segment, 2014-2021 19
3.2.5 Bone Growth Stimulators Market, Italy, Revenue ($m), by Segment, 2014-2021 21
3.2.6 Viscosupplementation Market, Italy, Revenue ($m), by Segment, 2014-2021 23
3.3 Orthobiologics Market, Italy, Volume (Units), 2007-2014 25
3.4 Orthobiologics Market, Italy, Volume (Units), 2014-2021 27
3.4.1 Bone Grafts and Substitutes Market, Italy, Volume (Units), by Segment, 2007-2014 29
3.4.2 Bone Growth Stimulators Market, Italy, Volume (Units), by Segment, 2007-2014 31
3.4.3 Viscosupplementation Market, Italy, Volume (Units), by Segment, 2007-2014 33
3.4.4 Bone Grafts and Substitutes Market, Italy, Volume (Units), by Segment, 2014-2021 35
3.4.5 Bone Growth Stimulators Market, Italy, Volume (Units), by Segment, 2014-2021 37
3.4.6 Viscosupplementation Market, Italy, Volume (Units), by Segment, 2014-2021 39
3.5 Orthobiologics Market, Italy, Average Price ($), 2007-2021 41
3.6 Orthobiologics Market, Italy, Distribution Share by Revenue ($m), 2013-2014 43
3.7 Orthobiologics Market, Italy, Company Share by Revenue ($m), 2014 44
4 Overview of Key Companies in Italy, Orthobiologics Market 46
4.1 Medtronic plc 46
4.1.1 Company Overview 46
4.2 DePuy Companies 46
4.2.1 Company Overview 46
4.3 Sanofi 46
4.3.1 Company Overview 46
4.4 Baxter International Inc. 47
4.4.1 Company Overview 47
4.5 Bioventus LLC 47
4.5.1 Company Overview 47
4.6 Biomet, Inc. (Inactive) 47
4.6.1 Company Overview 47
4.7 Arthrex, Inc. 47
4.7.1 Company Overview 47
4.8 DJO Finance LLC 48
4.8.1 Company Overview 48
4.9 Anika Therapeutics, Inc. 48
4.9.1 Company Overview 48
4.10 Seikagaku Corporation 48
4.10.1 Company Overview 48
4.11 Rottapharm Madaus GmbH 49
4.11.1 Company Overview 49
5 Orthobiologics Market Pipeline Products 50
6 Appendix 54
6.1 Research Methodology 55
6.1.1 Coverage 55
6.1.2 Secondary Research 55
6.1.3 Primary Research 56
6.1.4 Market Modeling and Forecasting 57
6.1.5 Company Share Analysis 60
6.1.6 Distribution Share Analysis 61
6.2 Expert Panel 62
6.3 GlobalData Consulting 62
6.4 Contact Us 62
6.5 Disclaimer 62

1.1 List of Tables
Table 1: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 10
Table 2: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 12
Table 3: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 14
Table 4: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 16
Table 5: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 18
Table 6: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 20
Table 7: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 22
Table 8: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 24
Table 9: Orthobiologics Market, Italy, Volume (Units), Historic, 2007-2014 26
Table 10: Orthobiologics Market, Italy, Volume (Units), Forecast, 2014-2021 28
Table 11: Bone Grafts and Substitutes Market, Italy, Volume (Units), Historic, 2007-2014 30
Table 12: Bone Growth Stimulators Market, Italy, Volume (Units), Historic, 2007-2014 32
Table 13: Viscosupplementation Market, Italy, Volume (Units), Historic, 2007-2014 34
Table 14: Bone Grafts and Substitutes Market, Italy, Volume (Units), Forecast, 2014-2021 36
Table 15: Bone Growth Stimulators Market, Italy, Volume (Units), Forecast, 2014-2021 38
Table 16: Viscosupplementation Market, Italy, Volume (Units), Forecast, 2014-2021 40
Table 17: Orthobiologics Market, Italy, Average Price ($) Historic, 2007-2014 41
Table 18: Orthobiologics Market, Italy, Average Price ($), Forecast, 2014-2021 42
Table 19: Orthobiologics Market, Italy, Distribution Share by Revenue ($m), USD Constant, 2013-2014 43
Table 20: Orthobiologics Market, Italy, Company Share by Revenue ($m), USD Constant, 2014 45
Table 21: Orthobiologics Market Pipeline Products 50
Table 22: Total Number of Primary Research Participants, Orthopedic Devices Market, by Country 57

1.2 List of Figures
Figure 1: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 9
Figure 2: Orthobiologics Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 11
Figure 3: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 13
Figure 4: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 15
Figure 5: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, Historic, 2007-2014 17
Figure 6: Bone Grafts and Substitutes Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 19
Figure 7: Bone Growth Stimulators Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 21
Figure 8: Viscosupplementation Market, Italy, Revenue ($m), USD Constant, Forecast, 2014-2021 23
Figure 9: Orthobiologics Market, Italy, Volume (Units), Historic, 2007-2014 25
Figure 10: Orthobiologics Market, Italy, Volume (Units), Forecast, 2014-2021 27
Figure 11: Bone Grafts and Substitutes Market, Italy, Volume (Units), Historic, 2007-2014 29
Figure 12: Bone Growth Stimulators Market, Italy, Volume (Units), Historic, 2007-2014 31
Figure 13: Viscosupplementation Market, Italy, Volume (Units), Historic, 2007-2014 33
Figure 14: Bone Grafts and Substitutes Market, Italy, Volume (Units), Forecast, 2014-2021 35
Figure 15: Bone Growth Stimulators Market, Italy, Volume (Units), Forecast, 2014-2021 37
Figure 16: Viscosupplementation Market, Italy, Volume (Units), Forecast, 2014-2021 39
Figure 17: Orthobiologics Market, Italy, Company Share (%) 2014 44
Figure 18: GlobalData Epidemiology-Based Forecasting Model 59
Figure 19: GlobalData Capital Equipment-Based Forecasting Model 60
Figure 20: Primary Interviews by Participant Type (%) 61

【掲載企業】

Medtronic plc
DePuy Companies
Sanofi
Baxter International Inc.
Bioventus LLC
Arthrex, Inc.
DJO Finance LLC
Anika Therapeutics, Inc.
Seikagaku Corporation
Rottapharm Madaus GmbH

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ イタリアのオーソバイオロジクス市場動向(~2021)(Italy Orthobiologics Market Outlook to 2021)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆